CV Sciences (CVSI) Share-based Compensation Growth (1y) (2015 - 2026)
CV Sciences (CVSI) Share-based Compensation Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 5.26% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -36.59% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -0.11% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | -49.74% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -18.06% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 23.11% |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | -65.00% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Mar 31, 2026 | 832.20% |
| Dec 31, 2025 | 18.27% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 293.33% |
| Dec 31, 2024 | 215.15% |
| Sep 30, 2024 | 2,400.00% |
| Jun 30, 2024 | 2,471.43% |
| Mar 31, 2024 | -74.58% |
| Dec 31, 2023 | -95.03% |
| Jun 30, 2023 | 120.47% |
| Mar 31, 2023 | -77.13% |
| Dec 31, 2022 | -20.48% |
| Jun 30, 2022 | -118.75% |
| Mar 31, 2022 | -21.46% |
| Dec 31, 2021 | 9.15% |
| Sep 30, 2021 | 31.06% |
| Jun 30, 2021 | -26.63% |
| Mar 31, 2021 | -47.77% |